STOCK TITAN

Planned ANAB share sale follows prior insider trade (NASDAQ: ANAB)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AnaptysBio insider files to sell common stock under Rule 144. A holder plans to sell 4,219 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/05/2026 on NASDAQ, with an aggregate market value of $189,644.05. The filing notes 28,023,368 shares of the issuer’s common stock outstanding, providing a baseline for the company’s share count. The shares to be sold were acquired as restricted stock units from the issuer on 01/05/2026, with payment listed as cash on the same date.

The form also reports that Paul F. Lizzul sold 1,500 common shares on 12/22/2025 for gross proceeds of $75,000 during the prior three months. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ANAB shares are planned to be sold under this Rule 144 notice?

The notice covers a planned sale of 4,219 shares of ANAB common stock, with an aggregate market value of $189,644.05.

When and where are the ANAB shares expected to be sold?

The approximate sale date is 01/05/2026, and the common stock is expected to be sold on the NASDAQ.

Which broker is handling the planned ANAB stock sale?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

How were the ANAB shares being sold acquired by the holder?

The 4,219 ANAB common shares were acquired on 01/05/2026 as restricted stock units from the issuer, with the consideration described as cash paid on the same date.

How many ANAB shares are outstanding according to this notice?

The filing states that there are 28,023,368 shares of ANAB common stock outstanding, providing a baseline figure for the issuer’s share count.

What ANAB stock sales occurred in the past three months for this seller?

The form reports that Paul F. Lizzul sold 1,500 ANAB common shares on 12/22/2025 for $75,000 in gross proceeds.

What representation does the seller make about ANAB’s information in this notice?

By signing, the seller represents that they do not know any material adverse information about ANAB’s current or prospective operations that has not been publicly disclosed.
Anaptysbio Inc

NASDAQ:ANAB

ANAB Rankings

ANAB Latest News

ANAB Latest SEC Filings

ANAB Stock Data

1.33B
26.01M
5.82%
124.31%
34.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO